Boothbay Fund Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,361
| Closed | -$1.19M | – | 1319 |
|
|
2024
Q4 | $1.19M | Buy |
15,361
+1,308
| +9% | +$102K | 0.03% | 486 |
|
|
2024
Q3 | $942K | Sell |
14,053
-19,074
| -58% | -$1.28M | 0.02% | 638 |
|
|
2024
Q2 | $3.76M | Buy |
33,127
+19,398
| +141% | +$2.2M | 0.09% | 260 |
|
|
2024
Q1 | $1.9M | Buy |
+13,729
| New | +$1.9M | 0.04% | 444 |
|
|
2023
Q4 | – | Sell |
-63,677
| Closed | -$5.94M | – | 1553 |
|
|
2023
Q3 | $5.94M | Buy |
63,677
+60,397
| +1,841% | +$5.64M | 0.14% | 130 |
|
|
2023
Q2 | $422K | Buy |
+3,280
| New | +$422K | 0.01% | 991 |
|
|
2022
Q2 | – | Sell |
-6,476
| Closed | -$828K | – | 2051 |
|
|
2022
Q1 | $828K | Sell |
6,476
-200
| -3% | -$25.6K | 0.02% | 818 |
|
|
2021
Q4 | $896K | Buy |
6,676
+3,780
| +131% | +$507K | 0.02% | 679 |
|
|
2021
Q3 | $396K | Buy |
+2,896
| New | +$396K | 0.01% | 996 |
|
|
2020
Q2 | – | Sell |
-5,896
| Closed | -$397K | – | 875 |
|
|
2020
Q1 | $397K | Buy |
+5,896
| New | +$397K | 0.03% | 421 |
|
|
2017
Q1 | – | Sell |
-17,208
| Closed | -$257 | – | 700 |
|
|
2016
Q4 | $257 | Buy |
+17,208
| New | +$257 | 0.06% | 410 |
|